Cardiac abnormalities in acromegaly. Pathophysiology and implications for management.

作者: Giovanni Vitale , Rosario Pivonello , Gaetano Lombardi , Annamaria Colao

DOI: 10.2165/00024677-200403050-00004

关键词:

摘要: Cardiovascular disease is claimed to be one of the most severe complications acromegaly, contributing significantly mortality in this disease. In fact, an excess growth hormone (GH) and insulin-like factor 1 (IGF-I) causes a specific derangement cardiomyocytes, leading abnormalities cardiac muscle structure function, inducing cardiomyopathy. early phase acromegaly GH IGF-I induces hyperkinetic syndrome, characterized by increased heart rate systolic output. Concentric hypertrophy common feature involvement found more than two thirds patients at diagnosis. This abnormality commonly associated with diastolic dysfunction eventually impaired function ending failure, if GH/IGF-I left untreated. addition, rhythm valves have also been described acromegaly. The coexistence other complications, such as arterial hypertension diabetes mellitus, aggravates acromegalic Successful control decrease ventricular mass improvement while effects suppression on are variable. However, since cardiovascular alterations young short duration milder those longer duration, it likely easier reverse and/or arrest cardiomyopathy early-onset conclusion, careful assessments morphology, activity required An diagnosis prompt effective treatment important order

参考文章(140)
B Surawicz, M L Mangiardi, Electrocardiogram in endocrine and metabolic disorders Cardiovascular clinics. ,vol. 8, pp. 243- 266 ,(1977)
Lancranjan, Atkinson, Sandostatin® LAR® Group#, Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group. Pituitary. ,vol. 1, pp. 105- 114 ,(1999) , 10.1023/A:1009980404404
Hypotension and adrenal insufficiency. Journal of Clinical Anesthesia. ,vol. 11, pp. 425- 430 ,(1999) , 10.1016/S0952-8180(99)00072-0
Giovanni Vitale, Rosario Pivonello, Maurizio Galderisi, Arcangelo D'Errico, Letizia Spinelli, Giovanni Lupoli, Gaetano Lombardi, Annamaria Colao, Cardiovascular complications in acromegaly: methods of assessment. Pituitary. ,vol. 4, pp. 251- 257 ,(2001) , 10.1023/A:1020750514954
D M Hill, T R Fraser, A D Wright, C Lowy, Mortality in acromegaly. QJM: An International Journal of Medicine. ,vol. 39, pp. 1- 16 ,(1970)
ACROMEGALY AND THE HEART: A CLINICAL AND PATHOLOGIC STUDY* Annals of Internal Medicine. ,vol. 34, pp. 1445- 1456 ,(1951) , 10.7326/0003-4819-34-6-1445
Gonzalo F. Maldonado Castro, Héctor F. Escobar-Morreale, Henar Ortega, Diego Gómez-Coronado, José A. Balsa Barro, César Varela, Miguel A. Lasunción, Effects of normalization of GH hypersecretion on lipoprotein(a) and other lipoprotein serum levels in acromegaly Clinical Endocrinology. ,vol. 53, pp. 313- 319 ,(2000) , 10.1046/J.1365-2265.2000.01092.X
M Evans, Davies, Goodfellow, Rees, Scanlon, Endothelial dysfunction in hypopituitary adults with growth hormone deficiency Clinical Endocrinology. ,vol. 50, pp. 457- 464 ,(1999) , 10.1046/J.1365-2265.1999.00671.X
Krzysztof Reiss, Leonard G. Meggs, Peng Li, Giorgio Olivetti, Joseph M. Capasso, Piero Anversa, Upregulation of IGF1, IGF1‐receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats Journal of Cellular Physiology. ,vol. 158, pp. 160- 168 ,(1994) , 10.1002/JCP.1041580120
Giovanni Vitale, Maurizio Galderisi, Rosario Pivonello, Letizia Spinelli, Antonio Ciccarelli, Oreste de Divitiis, Gaetano Lombardi, Annamaria Colao, Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass Clinical Endocrinology. ,vol. 60, pp. 343- 349 ,(2004) , 10.1111/J.1365-2265.2004.01985.X